SCHEMBL9937557

SCHEMBL9937557

CC(C)(C)c1ccccc1C(=O)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 7/20 0.38
MEN1 O00255 4/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
ESR1 P03372 4/20 0.37
ESR2 Q92731 3/20 0.37
PKM P14618 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NR1H4 Q96RI1 4/20 0.34
F12 P00748 2/20 0.33
ALDH1A1 P00352 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937599 0.86 KMT2A (0.53) MAPTKMT2AMEN1NPC1CASP3
SCHEMBL23199773 0.85 HSD17B10 (0.44) MAPTPOLBKMT2AMEN1NPC1
SCHEMBL669403 0.82 KMT2A (0.55) MAPTPOLBKMT2AMEN1ESR1
SCHEMBL9938614 0.80 MEN1 (0.42) KMT2AMEN1
SCHEMBL9937518 0.79 KMT2A (0.38) MAPTPOLBKMT2AMEN1NPC1
SCHEMBL668901 0.79 CA12 (0.41) MAPTPOLBKMT2AMEN1PKM
SCHEMBL996026 0.79 CA12 (0.41) MAPTPOLBKMT2AMEN1PKM
SCHEMBL9938286 0.78 ACHE (0.38) ALDH1A1
Hydrochloric Acid SCHEMBL23199797 0.78 CA2 (0.34) KMT2AMEN1
SCHEMBL9937653 0.77 KMT2A (0.37) MAPTPOLBKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed